Divalproex Long-Acting Tablets and Insulin Glargine (U-300) Pens
Determining the interaction of Divalproex Long-Acting Tablets and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Long-Acting Tablets-Insulin glargine and lixisenatide
- Divalproex Long-Acting Tablets-Insulin glargine and lixisenatide Subcutaneous
- Divalproex Long-Acting Tablets-Insulin glargine, recombinant Subcutaneous
- Divalproex Long-Acting Tablets-Insulin glulisine
- Divalproex Long-Acting Tablets-Insulin Glulisine (Cartridges and Pens)
- Divalproex Long-Acting Tablets-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Divalproex sodium
- Insulin Glargine (U-300) Pens-Divalproex Sprinkle
- Insulin Glargine (U-300) Pens-Divalproex Sprinkle Capsules
- Insulin Glargine (U-300) Pens-Divigel
- Insulin Glargine (U-300) Pens-Divigel 0.75 mg/packet for use on skin
- Insulin Glargine (U-300) Pens-Divigel Transdermal